A Charitability-Funded Public-Private Partnership Driving Towards Zero Preventable Heart Attack, Stroke, Diabetes, Heart Failure, and SARS-CoV-2 Deaths and Disabilities Through Best Available Science Combined with Proactive Screening and Outreach.
High Triglycerides Breakthrough Therapy: Icosapent Ethyl
William J. Bommer, MD, FACP, FACC – Statewide Chairman, Right Care Initiative University of Best Practices; Specialty Delegate, California American College of Cardiology and California Medical Association; Director, California ePCI Program; Director, Prevention Forward Program and Professor of Medicine, Division of Cardiovascular Medicine, University of California, Davis
Deepak Bhatt, MD, MPH, FACC, FAHA, FSCAI, FESC– Executive Director of Interventional Cardiovascular Programs; Professor, Harvard Medical School; Principal Investigator, REDUCE-IT Trial
Eligibility and Preventable Cardiovascular Events in US Population (Presentation|Video)
Nathan Wong, PhD, MPH, FACC, FAHA, FNLA, FASPC– Professor, School of Medicine & Department of Epidemiology; Director, UCI Heart Disease Prevention Program, School of Medicine; University of California, Irvine
William J. Bommer, MD, FACP, FACC – Statewide Chairman, Right Care Initiative University of Best Practices; Specialty Delegate, California American College of Cardiology and California Medical Association; Director, California ePCI Program; Director, Prevention Forward Program and Professor of Medicine, Division of Cardiovascular Medicine, University of California, Davis
